Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
Immunological analyses were supported in part by the Penn State Cancer Institute through the Clinical Correlative Immunology Laboratory (TDS, JPH)
Clinically significant drug-metabolizing enzyme- and transporter-mediated DDIs are yet to be reported
We report that while SEMA led to substantial weight loss, reduced tumor engraftment, blunted progression, and reduced tumor burden compared to Veh, RETA demonstrated superior effectiveness with remarkable and sustained weight loss, profound reductions in tumor engraftment, and significantly reduced tumor burden compared to SEMA, WM-CR, and Veh
Bertoni-Freddari C, Fattoretti P, Casoli T, Spagna C, Casell U
US$ 29.24
US$ 28.38
US$ 21.58
US$ 25.10
US$ 25.11
US$ 28.44
